Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS). - Zhang, Gan; Yu, Danfeng; Pan, Huan; Liu, Jiong; Wang, Ruling; Wan, Yunyan; Zhou, Wuhua; Wang, Huaxiang (Scientific Reports, 2025)